Category: Newsflash

This is amazing!! They have found that inhibiting a specific protein eliminated metastasis of melanoma in laboratory experiments, a finding that could lead to targeted therapies to stop metastasis in not only melanoma but, potentially, a broad range of cancers.  WOW! We are getting close  Read more http://www.oncologynurseadvisor.com/suppressed-protein-halted-melanoma-metastasis/article/271157/  

Doug Macron is the editor of GenomeWeb’s Gene Silencing News. He covers research and therapeutic applications of RNAi, miRNA, and other gene-silencing technologies. E-mail him here or follow his GenomeWeb Twitter account at @Genesilencing.

Combination therapy of Thymosin with dacarbazine and interferon alpha. Thymosin is a peptide released by the thymus gland. http://www.ncbi.nlm.nih.gov/pubmed/23050811 Yervoy causes inflammation in Melanoma. Teaming Yervoy with a T-cell therapy makes a lot of sense… http://www.chemotherapyadvisor.com/inflammation-induces-melanomas-invisibility-to-t-cell-immunotherapy/article/263930/

Testing the cancer stem cell hypothesis in melanoma: the clinics will tell. Abstract:  Whether tumorigenic cancer stem cells (CSCs) exist in melanoma has been the focus of much controversy in recent years. A number of studies have pointed to the existence of melanoma cell sub-populations that act as CSCs and can be distinguished from other…